We seek to understand the molecular pharmacology of therapeutics and drugs of abuse targeting the monoamine neurotransmitter transporters and/or receptors. We also study experimental antidepressants to elucidate which properties and targets are important for their antidepressant and hallucinogenic action.
We improve the public sector consultancy within forensic toxicology through research by developing new methods to increase the detection of drugs in both dead and living as well as upgrading the toxicological interpretation. We apply state of the art mass spectrometry, metabolomics and pharmacology.